| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $63.4B | $61.6B | $58.0B | $50.6B | $29.9B | $17.1B | $11.4B | $10.7B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $5.8B | $6.0B | $5.5B | $3.7B | $1.9B | $-12.5B | $1.4B | $1.1B |
| Net Income | $5.0B | $3.5B | $4.6B | $1.3B | $0.3B | $-12.4B | $1.1B | $1.0B |
| EPS (Basic) | $7.72 | $5.39 | $7.21 | $2.07 | $0.44 | $-19.49 | $1.71 | $1.50 |
| EPS (Diluted) | $7.66 | $5.33 | $7.17 | $2.06 | $0.44 | $-19.49 | $1.71 | $1.49 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $81.3B | $75.4B | $73.6B | $72.3B | $72.5B | $72.0B | $64.5B | $60.3B |
| Current Assets | $11.0B | $9.8B | $10.3B | $13.0B | $15.9B | $17.4B | $8.2B | $6.3B |
| Cash & Equivalents | $4.3B | $3.1B | $2.7B | $3.3B | $7.9B | $8.3B | $2.9B | $1.6B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $27.6B | $26.7B | $26.4B | $25.9B | $21.0B | $15.9B | $20.2B | $18.6B |
| Stockholders' Equity | $20.9B | $15.3B | $11.1B | $6.6B | $3.9B | $1.5B | $15.4B | $13.7B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $8.3B | $8.0B | $6.5B | $6.4B | $3.3B | $-3.8B | $8.4B | $7.0B |
| Investing Cash Flow | $-4.2B | $-3.7B | $-3.1B | $-6.9B | $-0.9B | $-9.2B | $-4.6B | $-4.4B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-3.1B | $-4.3B | $-3.4B | $-4.5B | $-3.9B | $19.4B | $-2.9B | $-1.7B |